A new study is alerting people who take a common drug for Irritable Bowel Disease (IBD) that their body’s response to the first COVID-19 vac...
A new study is alerting people who take a common drug for Irritable Bowel Disease (IBD) that their body’s response to the first COVID-19 vaccine dose may be lower than expected. The issue was observed in people taking an immune-suppressing drug called infliximab, which is commonly prescribed for IBD. Vaccines, including the COVID-19 vaccine, work by triggering the patient’s own … Continue reading
from SlashGear https://ift.tt/3vpl31U
via IFTTT
from SlashGear https://ift.tt/3vpl31U
via IFTTT
COMMENTS